These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21048156)

  • 1. Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers.
    Pillozzi S; Masselli M; De Lorenzo E; Accordi B; Cilia E; Crociani O; Amedei A; Veltroni M; D'Amico M; Basso G; Becchetti A; Campana D; Arcangeli A
    Blood; 2011 Jan; 117(3):902-14. PubMed ID: 21048156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
    Fortunato A
    Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and functional interaction between integrins and hERG1 channels in cancer cells.
    Pillozzi S; Arcangeli A
    Adv Exp Med Biol; 2010; 674():55-67. PubMed ID: 20549940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGFR-1 (FLT-1), beta1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome.
    Pillozzi S; Brizzi MF; Bernabei PA; Bartolozzi B; Caporale R; Basile V; Boddi V; Pegoraro L; Becchetti A; Arcangeli A
    Blood; 2007 Aug; 110(4):1238-50. PubMed ID: 17420287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression.
    Becchetti A; Crescioli S; Zanieri F; Petroni G; Mercatelli R; Coppola S; Gasparoli L; D'Amico M; Pillozzi S; Crociani O; Stefanini M; Fiore A; Carraresi L; Morello V; Manoli S; Brizzi MF; Ricci D; Rinaldi M; Masi A; Schmidt T; Quercioli F; Defilippi P; Arcangeli A
    Sci Signal; 2017 Apr; 10(473):. PubMed ID: 28377405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of hERG1 K+ channels and a functional link between hERG1 K+ channels and SDF-1 in acute leukemic cell migration.
    Li H; Du YM; Guo L; Jie S; Zhang S; Du W; Chen X; Liu W; Fan L; Zhu J; Zou A; Huang S
    Exp Cell Res; 2009 Aug; 315(13):2256-64. PubMed ID: 19409379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer.
    Crociani O; Zanieri F; Pillozzi S; Lastraioli E; Stefanini M; Fiore A; Fortunato A; D'Amico M; Masselli M; De Lorenzo E; Gasparoli L; Chiu M; Bussolati O; Becchetti A; Arcangeli A
    Sci Rep; 2013 Nov; 3():3308. PubMed ID: 24270902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing the hERG1/β1 Integrin Complex via a Novel Bispecific Single-chain Antibody: An Effective Strategy against Solid Cancers.
    Duranti C; Iorio J; Lottini T; Lastraioli E; Crescioli S; Bagni G; Lulli M; Capitani C; Bouazzi R; Stefanini M; Carraresi L; Iamele L; De Jonge H; Arcangeli A
    Mol Cancer Ther; 2021 Aug; 20(8):1338-1349. PubMed ID: 34045227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hERG1 K(+) channels in leukemia cells as a positive regulator in SDF-1a-induced proliferation.
    Zheng F; Li H; Du W; Huang S
    Hematology; 2011 May; 16(3):177-84. PubMed ID: 21669058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human ether-a-go-go-related gene K+ channels regulate shedding of leukemia cell-derived microvesicles.
    Zheng F; Li J; Du W; Wang N; Li H; Huang S
    Leuk Lymphoma; 2012 Aug; 53(8):1592-8. PubMed ID: 22292854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the hERG1 and β1 integrin complex for cancer treatment.
    Arcangeli A; Iorio J; Duranti C
    Expert Opin Ther Targets; 2024 Mar; 28(3):145-157. PubMed ID: 38372580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow‑induced chemoresistance in acute leukemias.
    Pillozzi S; Bernini A; Spiga O; Lelli B; Petroni G; Bracci L; Niccolai N; Arcangeli A
    Oncol Rep; 2019 Jan; 41(1):312-324. PubMed ID: 30365110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term channel block is required to inhibit cellular transformation by human ether-à-go-go-related gene (hERG1) potassium channels.
    Pier DM; Shehatou GS; Giblett S; Pullar CE; Trezise DJ; Pritchard CA; Challiss RA; Mitcheson JS
    Mol Pharmacol; 2014 Aug; 86(2):211-21. PubMed ID: 24830940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Link between Inactivation and High-Affinity Block of hERG1 Channels.
    Wu W; Gardner A; Sanguinetti MC
    Mol Pharmacol; 2015 Jun; 87(6):1042-50. PubMed ID: 25855787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human ether-a-go-go-related gene 1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signaling.
    Cherubini A; Hofmann G; Pillozzi S; Guasti L; Crociani O; Cilia E; Di Stefano P; Degani S; Balzi M; Olivotto M; Wanke E; Becchetti A; Defilippi P; Wymore R; Arcangeli A
    Mol Biol Cell; 2005 Jun; 16(6):2972-83. PubMed ID: 15800067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of potassium channels in tumours of the gastrointestinal tract: a focus on the human ether-à-go-go related gene 1 channels.
    Arcangeli A; Duranti C; Iorio J; Lastraioli E
    J Physiol; 2023 May; 601(9):1597-1610. PubMed ID: 36215066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption.
    Zhao H; Shi P; Deng M; Jiang Z; Li Y; Kannappan V; Wang W; Li P; Xu B
    Oncotarget; 2016 Dec; 7(51):85515-85528. PubMed ID: 27888802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.
    Slone WL; Moses BS; Hare I; Evans R; Piktel D; Gibson LF
    Oncotarget; 2016 Apr; 7(17):23439-53. PubMed ID: 27015556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting ion channels in leukemias: a new challenge for treatment.
    Arcangeli A; Pillozzi S; Becchetti A
    Curr Med Chem; 2012; 19(5):683-96. PubMed ID: 22204341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.